Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Phys Med Biol. 2012 Feb 7;57(3):591-608. doi: 10.1088/0031-9155/57/3/591. Epub 2012 Jan 6.
We present a method to include robustness in a multi-criteria optimization (MCO) framework for intensity-modulated proton therapy (IMPT). The approach allows one to simultaneously explore the trade-off between different objectives as well as the trade-off between robustness and nominal plan quality. In MCO, a database of plans each emphasizing different treatment planning objectives, is pre-computed to approximate the Pareto surface. An IMPT treatment plan that strikes the best balance between the different objectives can be selected by navigating on the Pareto surface. In our approach, robustness is integrated into MCO by adding robustified objectives and constraints to the MCO problem. Uncertainties (or errors) of the robust problem are modeled by pre-calculated dose-influence matrices for a nominal scenario and a number of pre-defined error scenarios (shifted patient positions, proton beam undershoot and overshoot). Objectives and constraints can be defined for the nominal scenario, thus characterizing nominal plan quality. A robustified objective represents the worst objective function value that can be realized for any of the error scenarios and thus provides a measure of plan robustness. The optimization method is based on a linear projection solver and is capable of handling large problem sizes resulting from a fine dose grid resolution, many scenarios, and a large number of proton pencil beams. A base-of-skull case is used to demonstrate the robust optimization method. It is demonstrated that the robust optimization method reduces the sensitivity of the treatment plan to setup and range errors to a degree that is not achieved by a safety margin approach. A chordoma case is analyzed in more detail to demonstrate the involved trade-offs between target underdose and brainstem sparing as well as robustness and nominal plan quality. The latter illustrates the advantage of MCO in the context of robust planning. For all cases examined, the robust optimization for each Pareto optimal plan takes less than 5 min on a standard computer, making a computationally friendly interface possible to the planner. In conclusion, the uncertainty pertinent to the IMPT procedure can be reduced during treatment planning by optimizing plans that emphasize different treatment objectives, including robustness, and then interactively seeking for a most-preferred one from the solution Pareto surface.
我们提出了一种将稳健性纳入强度调制质子治疗(IMPT)的多准则优化(MCO)框架的方法。该方法允许同时探索不同目标之间的权衡以及稳健性和名义计划质量之间的权衡。在 MCO 中,通过预先计算强调不同治疗计划目标的计划数据库来近似 Pareto 曲面。通过在 Pareto 曲面上导航,可以选择在不同目标之间取得最佳平衡的 IMPT 治疗计划。在我们的方法中,稳健性通过向 MCO 问题添加稳健化的目标和约束来集成到 MCO 中。通过为名义情况和多个预定义的误差情况(患者位置偏移、质子束不足和过量)预先计算剂量影响矩阵来对稳健问题的不确定性(或误差)进行建模。可以为名义情况定义目标和约束,从而表征名义计划质量。稳健化目标代表在任何误差情况下都可以实现的最差目标函数值,因此提供了计划稳健性的度量。该优化方法基于线性投影求解器,能够处理由于剂量网格分辨率精细、许多情况和大量质子铅笔束而导致的大型问题尺寸。使用颅底案例来演示稳健优化方法。结果表明,稳健优化方法降低了治疗计划对设置和范围误差的敏感性,达到了安全裕度方法无法实现的程度。更详细地分析了脊索瘤案例,以演示目标低估和脑干保护以及稳健性和名义计划质量之间的相关权衡。后者说明了在稳健规划背景下 MCO 的优势。对于检查的所有情况,对于每个 Pareto 最优计划的稳健优化在标准计算机上不到 5 分钟,这使得为规划师提供一个计算友好的界面成为可能。总之,通过优化强调不同治疗目标(包括稳健性)的计划,并从解决方案 Pareto 曲面中交互式地寻找最优选,可以在治疗计划期间降低与 IMPT 过程相关的不确定性。